Workshop at Goring Hotel, London, 11-12 January 1999

Haemophilia

Volumn 5, Issue 3, 1999, Pages 216-219

  Aledort, Louis M ^a   Miners, Alec ^a   Bohn, R ^a   Borrero, P ^a   Goudemand, J ^a   Hoots, K ^a   Kavakli, K ^a   Lee, C ^a   Roberts, J ^a   Schramm, W ^a   Szucs, T ^a   Wasserman, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLOOD CLOTTING FACTOR 7A; FIBRIN GLUE; RIBAVIRIN; SEDATIVE AGENT; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR;

CIRCUMCISION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH ECONOMICS; HEMOPHILIA; HUMAN; IATROGENIC DISEASE; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; COST BENEFIT ANALYSIS; ECONOMICS; HEMOPHILIA A; PSYCHOLOGICAL ASPECT;

BLOOD COAGULATION FACTORS; COST-BENEFIT ANALYSIS; HEMOPHILIA A; HUMANS; QUALITY OF LIFE;

EID: 0033126348     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.00325.x     Document Type: Conference Paper

References (7)

1. Szucs T, Öffner A, Schramm W. Socioeconomic impact of haemophilia care: results of a pilot study. Haemophilia 1996; 2: 211-17.
2. Nilsson IM, Berntop E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
3. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes Oxford: Oxford University Press, 1997.
4. The EuroQol Group. EuroQol-a new facility for the measurement of health related quality of life. Health Policy 1994; 16: 655-62.
5. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Ebrahim S, Lee CA. Assessing health-related quality-of-life in patients with severe haemophilia A and B. Psychol Health Med 1999; 4: 5-16.
6. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alpha: an economic appraisal. Hepatol 1995; 22: 1800-1802.
7. Kavakli K, Nisli G, Ozcan C, et al. Safer and much cheaper circumcision using fibrin glue in severe haemophilia. Haemophilia 1997; 3: 209-11.